Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 7/6/2012
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Wallace Akerley, MD |
None |
Genentech, Inc. |
None |
None |
3/5/2013 |
Hossein Borghaei, DO, MS |
Genentech, Inc.; |
Amgen Inc.; |
None |
None |
7/2/2012 |
Andrew C. Chang, MD |
None |
None |
None |
None |
5/15/2013 |
Richard T. Cheney, MD |
None |
OptumHealth |
None |
None |
7/3/2012 |
Lucian R. Chirieac, MD |
None |
Boehringer Ingelheim GmbH; |
None |
None |
5/1/2012 |
Thomas A. D'Amico, MD |
None |
Scanlan |
None |
None |
2/28/2013 |
Todd L. Demmy, MD |
None |
None |
None |
None |
10/12/2012 |
David S. Ettinger, MD, FACP, FCCP |
None |
Boehringer Ingelheim GmbH; |
None |
None |
2/28/2013 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
6/5/2012 |
Ramaswamy Govindan, MD |
None |
AstraZeneca Pharmaceuticals LP; |
None |
None |
3/28/2012 |
Frederic W. Grannis, MD |
None |
Steven Phillips (sphillips@lpklaw.com) |
None |
City of Hope National Medical Center Board of Directors |
6/18/2012 |
Stefan C. Grant, MD, JD |
None |
None |
None |
None |
5/14/2012 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
10/23/2012 |
Leora Horn, MD, MSc, FRCPC |
None |
None |
None |
None |
8/16/2012 |
Miranda Hughes, PhD |
None |
None |
None |
None |
4/10/2013 |
Thierry M. Jahan, MD |
None |
None |
None |
None |
4/16/2013 |
Melissa Johnson, MD |
Novartis Pharmaceuticals Corporation |
None |
None |
None |
7/5/2012 |
Ritsuko Komaki, MD |
Pfizer Inc. |
None |
None |
None |
7/3/2012 |
Feng-Ming (Spring) Kong, MD, PhD |
None |
None |
None |
None |
10/9/2012 |
Mark G. Kris, MD |
None |
Genentech, Inc.; |
None |
None |
3/4/2013 |
Lee M. Krug, MD |
Eli Lilly and Company; |
Genentech, Inc.; |
None |
None |
6/18/2012 |
Rudy P. Lackner, MD |
None |
None |
None |
None |
3/2/2013 |
Inga T. Lennes, MD |
None |
None |
None |
None |
6/18/2012 |
Billy W. Loo, MD, PhD |
None |
None |
None |
Siemens Medical Solutions Diagnostics; |
3/20/2013 |
Renato Martins, MD, MPH |
None |
Eli Lilly and Company; |
None |
None |
4/8/2013 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/23/2012 |
Gregory A. Otterson, MD |
Abraxis Oncology; |
Abraxis Bioscience, Inc.; |
None |
None |
1/23/2013 |
Jyoti D. Patel, MD |
Eli Lilly and Company |
Genentech, Inc. |
None |
None |
3/26/2012 |
Mary C. Pinder-Schenck, MD |
Eli Lilly and Company; |
None |
None |
None |
7/3/2012 |
Katherine M. Pisters, MD |
None |
None |
None |
None |
4/10/2013 |
Karen Reckamp, MD, MS |
Amgen Inc.; |
Amgen Inc. |
None |
None |
3/5/2013 |
Gregory J. Riely, MD, PhD |
None |
ARIAD Pharmaceuticals, Inc.; |
None |
None |
8/16/2012 |
Eric Rohren, MD, PhD |
None |
None |
None |
None |
5/17/2013 |
Theresa A. Shapiro, MD, PhD |
None |
None |
None |
None |
5/4/2012 |
Scott Swanson, MD |
None |
Covidien AG; |
None |
None |
7/5/2012 |
Kurt Tauer, MD |
None |
Eli Lilly and Company |
None |
None |
7/5/2012 |
Douglas E. Wood, MD |
None |
None |
None |
None |
5/11/2013 |
Stephen C. Yang, MD |
None |
None |
None |
None |
6/18/2012 |
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved